Stornello 1992

Methods	Country: Italy Setting/Design: University Time frame: NS Randomisation method: Yes Blinding ‐ Participants: No ‐ Investigators: No ‐ Outcome assessors: No ‐ Data analysis: No Intention‐to‐treat: Yes Follow‐up period: 6 months x 2 Loss to follow‐up: 0
Participants	Inclusion criteria DM: Type 2 Persistent albuminuria: > 300 mg/24 h on at least 3 occasions Enalapril group Number: 12 Age: 46.9 (9.1) Sex (M/F): 6/6 Atenolol group Number: 12 Age: 46.9 (9.1) Sex (M/F): 6/6 Exclusion criteria Signs of other renal disease
Interventions	Enalapril group 5 mg/d Atenolol group 50 mg/d Co‐interventions: NS
Outcomes	BP GFR AER
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear